Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content
Fig. 1 | Molecular Autism

Fig. 1

From: Enhanced hippocampal LTP but normal NMDA receptor and AMPA receptor function in a rat model of CDKL5 deficiency disorder

Fig. 1

Validation of Cdkl5-/y rats. (A) Schematic of the Cdkl5 knockout strategy depicting the WT and null alleles. The null allele has a 10 bp (bp) deletion in exon 8 (region shown in blue in WT allele), leading to a frame shift and an in frame, premature STOP codon forming in exon 9 (*). (B) Genotyping results from male WT and Cdkl5−/y animals. Higher band in WT and Cdkl5−/y animals resulting from F1 and R primers product. Lower band in the WT samples resulting from F2 and R primer products is absent in the null samples due to the 10 bp deleted sequence. (C) Western blot showing the absence of CDKL5 in hippocampal and prefrontal cortex tissue preparations from WT and Cdkl5−/y rats. (D) Quantification of CDKL5 western blot protein expression in hippocampal and prefrontal cortex preparations. (E) Western blot showing the absence of CDKL5 in hippocampal synaptosome preparations from WT and Cdkl5−/y rats. (F) Quantification of CDKL5 western blot protein expression in hippocampal synaptosome preparations

Back to article page